Shanghai Pharmaceuticals Gets Clinical Trial Nod for Schizophrenia Tablets
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.75 CNY | +0.46% | +2.01% | -5.95% |
Jan. 02 | Billionaire Li Ka-shing's Hutchmed in $608 million health unit stake sales | RE |
Jan. 02 | Shanghai Pharmaceuticals Holding and Yunnan Baiyao Renew Sales Agreement for 2025 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration